AMGN
Amgen, Inc.
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $248.33
- Day High
- $249.43
- Day Low
- $247.25
- Day Open
- $247.43
- Volume
- 87760
- Day Change
- 0.45%
Latest news data for AMGN
North America breast cancer therapeutics market size to attain a valuation of USD 16 billion by 2028
globenewswire.com
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Molecular Partners AG of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2022 - (NASDAQ: MOLN)
prnewswire.com
Amgen (NASDAQ:AMGN) Price Target Cut to $182.00 by Analysts at Atlantic Securities
etfdailynews.com
Biopharmaceuticals Market with 7.5% CAGR Between 2022 to 2030, Top key players, Size, Share, Recent Developments, Opportunities, Challenges, Growth Plus Reports
globenewswire.com
Amgen (NASDAQ:AMGN) Rating Lowered to Buy at StockNews.com
etfdailynews.com
SHAREHOLDER ALERT: Weiss Law Reminds AAWW, CCXI, HNGR, and U Shareholders About Its Ongoing Investigations
prnewswire.com
MOLN LOSS ALERT: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Molecular Partners AG Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – M
globenewswire.com
Get ready for more merger mania in pharma sector the rest of the year
marketwatch.com
Eli Lilly Hits Some Bumps in the Road
gurufocus.com
Shareholder Alert - The M&A Class Action Firm Announces the Investigation of ChemoCentryx, Inc. - CCXI
prnewswire.com